Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kubel Vognsen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMJ Open Respiratory Research|January 27, 2026
COPD and vitamin K antagonism: a cohort study of 1-year all-cause mortality and risk of hospitalisation due to a severe exacerbationBård-Emil Vang Vang Gundersen, Anna Kubel Vognsen, Josefin Eklöf, et al.
Journal of Clinical Medicine|May 13, 2026
Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPDEmma Moerk Borremose, Victor Naestholt Dahl, Anna Kubel Vognsen, et al.
Journal of Clinical Medicine|December 11, 2025
Inhaled Corticosteroid Use and Risk of <i>Haemophilus influenzae</i> Isolation in Patients with Bronchiectasis: A Retrospective Cohort StudyDil Afrose, Christian Philip Rønn, Josefin Eklöf, et al.
BMC Pulmonary Medicine|December 3, 2025
Evening administration of long-acting muscarinic antagonists in COPD - a randomized controlled trialPradeesh Sivapalan, Valdemar Rømer, Alexander Jordan, et al.
Journal of Clinical Medicine|August 14, 2025
Inhaled Corticosteroids and Risk of <i>Staphylococcus aureus</i> Isolation in Bronchiectasis: A Register-Based Cohort StudyAndrea Arlund Filipsen, Karen Hougaard Frost, Josefin Eklöf, et al.
Scientific Reports|June 24, 2026
Collagen- and elastin-derived biomarkers and acute severe exacerbations in COPD: a sub study of the CORTICO-COP trialAsmus Solyom Høgdall, Jannie Marie Bülow Sand, Anna Kubel Vognsen, et al.
Scientific Reports|January 6, 2026
Plasma growth differentiation factor-15 is associated with cardiovascular events in patients hospitalized for acute exacerbation of COPDPradeesh Sivapalan, Daniel Alexander Ackermann, Anna Kubel Vognsen, et al.
Biomedicines|April 29, 2025
Low Vitamin K Status and Risk of Chronic Obstructive Pulmonary DiseaseDaniel Alexander Ackermann, Allan Linneberg, Ema Rastoder, et al.
The European Respiratory Journal|August 7, 2025
Pulmonary pressure increases during Acute Exacerbation in Chronic Obstructive Pulmonary Disease and clinical outcomeEma Rastoder, Pradeesh Sivapalan, Caroline Hedsund, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMJ Open Respiratory Research|January 27, 2026
COPD and vitamin K antagonism: a cohort study of 1-year all-cause mortality and risk of hospitalisation due to a severe exacerbationBård-Emil Vang Vang Gundersen, Anna Kubel Vognsen, Josefin Eklöf, et al.
Journal of Clinical Medicine|May 13, 2026
Inhaled Corticosteroids and Non-Tuberculous Mycobacteria Risk in Patients with COPDEmma Moerk Borremose, Victor Naestholt Dahl, Anna Kubel Vognsen, et al.
Journal of Clinical Medicine|December 11, 2025
Inhaled Corticosteroid Use and Risk of <i>Haemophilus influenzae</i> Isolation in Patients with Bronchiectasis: A Retrospective Cohort StudyDil Afrose, Christian Philip Rønn, Josefin Eklöf, et al.
BMC Pulmonary Medicine|December 3, 2025
Evening administration of long-acting muscarinic antagonists in COPD - a randomized controlled trialPradeesh Sivapalan, Valdemar Rømer, Alexander Jordan, et al.
Journal of Clinical Medicine|August 14, 2025
Inhaled Corticosteroids and Risk of <i>Staphylococcus aureus</i> Isolation in Bronchiectasis: A Register-Based Cohort StudyAndrea Arlund Filipsen, Karen Hougaard Frost, Josefin Eklöf, et al.
Scientific Reports|June 24, 2026
Collagen- and elastin-derived biomarkers and acute severe exacerbations in COPD: a sub study of the CORTICO-COP trialAsmus Solyom Høgdall, Jannie Marie Bülow Sand, Anna Kubel Vognsen, et al.
Scientific Reports|January 6, 2026
Plasma growth differentiation factor-15 is associated with cardiovascular events in patients hospitalized for acute exacerbation of COPDPradeesh Sivapalan, Daniel Alexander Ackermann, Anna Kubel Vognsen, et al.
Biomedicines|April 29, 2025
Low Vitamin K Status and Risk of Chronic Obstructive Pulmonary DiseaseDaniel Alexander Ackermann, Allan Linneberg, Ema Rastoder, et al.
The European Respiratory Journal|August 7, 2025
Pulmonary pressure increases during Acute Exacerbation in Chronic Obstructive Pulmonary Disease and clinical outcomeEma Rastoder, Pradeesh Sivapalan, Caroline Hedsund, et al.
Pageof 1